← Progyny, Inc.
| Annual Trend | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Net income | ($12.5m) |
$661k
+105.31%
|
($8.6m)
-1396.37%
|
$46.5m
+642.18%
|
$65.8m
+41.56%
|
$30.4m
-53.84%
|
$62.0m
+104.35%
|
$54.3m
-12.41%
|
$58.5m
+7.70%
|
$78.6m
+34.37%
|
|
| Depreciation and amortization | $1.6m | $1.9m | $2.1m | $1.9m | $1.3m | $1.6m | $2.3m | $3.2m | $4.9m | $5.7m | |
| Deferred tax (benefit) expense | ($3k) | ($1.8m) | $12k | ($38.0m) | ($33.3m) | ($6.6m) | $3.7m | ($10.5m) | ($8.1m) | — | |
| Stock-based compensation expense | $1.6m | $3.0m | $5.1m | $12.8m | $33.7m | $100.7m | $122.6m | $128.1m | $131.9m | $107.2m | |
| Accounts receivable | ($2.0m) | ($12.8m) | ($25.3m) | ($35.3m) | ($68.7m) | ($119.3m) | ($21.7m) | ($9.9m) | ($5.1m) | ($5.3m) | |
| Accounts payable | ($909k) | $10.4m | $3.5m | $25.0m | $17.8m | $47.7m | $16.2m | ($30.3m) | $28.8m | $11.4m | |
| Additions of property and equipment, net included in accounts payable and accrued expenses | — | — | — | $24k | $204k | $636k | $421k | $249k | $681k | — | |
| Accrued expenses and other current liabilities | $2.0m | $2.8m | $6.4m | $17.4m | $2.2m | $13.1m | $10.4m | $9.9m | $417k | — | |
| Prepaid expenses and other current assets | ($198k) | ($179k) | ($4.1m) | ($326k) | $675k | $57k | ($22.9m) | $18.0m | ($11.9m) | — | |
| Net cash provided by operating activities | ($9.5m) |
$2.3m
+123.98%
|
($1.5m)
-167.52%
|
$36.2m
+2460.04%
|
$26.0m
-28.08%
|
$80.4m
+208.77%
|
$188.8m
+134.86%
|
$179.1m
-5.14%
|
$210.2m
+17.36%
|
$201.2m
-4.26%
|
|
| Loss on disposal of property and equipment | $2k | — | $1k | — | — | $0 | $0 | $1.4m | $79k | — | |
| Purchase of property and equipment, net | ($612k) | ($579k) | ($3.0m) | ($1.0m) | ($2.1m) | ($3.2m) | ($3.6m) | ($5.4m) | ($18.4m) | ($22.9m) | |
| Net accretion of discounts on marketable securities | — | — | — | — | $0 | $0 | ($4.3m) | ($2.1m) | ($866k) | — | |
| Purchase of marketable securities | — | — | — | ($104.0m) | ($111.5m) | ($163.3m) | ($429.7m) | ($170.3m) | ($355.0m) | — | |
| Sale of marketable securities | — | — | — | $65.0m | $122.4m | $122.7m | $232.8m | $376.8m | $223.7m | — | |
| Net cash (used in) provided by investing activities | ($612k) | $1.9m | ($2.8m) | ($40.0m) | $8.8m | ($43.9m) | ($200.5m) | $195.8m | ($159.0m) | — | |
| Bad debt expense | $431k | $824k | $1.6m | $5.6m | $9.8m | $13.8m | $19.9m | $16.4m | $20.5m | — | |
| Repurchase of common stock | — | ($1.2m) | ($185k) | — | — | $0 | $0 | ($300.3m) | ($81.7m) | — | |
| Net cash used in financing activities | $11.8m |
($8.7m)
-174.26%
|
$84.5m
+1067.56%
|
($6.2m)
-107.39%
|
($13.7m)
-119.16%
|
($7.9m)
+42.58%
|
($11.1m)
-40.79%
|
($309.9m)
-2698.77%
|
($99.4m)
+67.94%
|
($249.8m)
-151.36%
|
|
| Net (decrease) increase in cash, cash equivalents, and restricted cash | — | — | — | ($10.1m) | $21.1m | $28.7m | ($22.8m) | $65.0m | ($48.1m) | — | |
| Cash, cash equivalents, and restricted cash, beginning of year | — | — | — | $70.3m | $91.4m | $120.1m | $97.3m | $162.3m | $114.2m | — | |
| Effect of exchange rate changes on cash, cash equivalents, and restricted cash | — | — | — | — | — | — | $1k | $1k | $62k | ($92k) | |
| Restricted cash included within other noncurrent assets | — | — | — | — | — | — | $0 | $0 | $2.0m | — | |
| Foreign currency exchange rate loss | — | — | — | — | $0 | $0 | ($8k) | $0 | $0 | — | |
| Additional Supplementary Disclosures | |||||||||||
| Additional Supplementary Disclosures | |||||||||||
| Non-cash interest expense (income) | — | — | — | $75k | $38k | $0 | ($34k) | $0 | $434k | — | |
| Other noncurrent assets and liabilities | — | $100k | ($380k) | $605k | ($3.3m) | ($1.1m) | $648k | $425k | ($9.3m) | — | |
| Acquisition of business, net of cash acquired | — | — | — | — | — | $0 | $0 | ($5.3m) | ($9.3m) | — | |
| Proceeds from exercise of stock options | $25k | $65k | $6.5m | $2.3m | $2.9m | $3.1m | $4.8m | $1.1m | $86k | — | |
| Issuance costs on credit facility | — | — | — | — | — | — | $0 | $0 | ($3.1m) | — | |
| Payment of employee taxes related to equity awards | — | — | — | ($8.9m) | ($18.0m) | ($12.1m) | ($17.2m) | ($12.0m) | ($15.8m) | — | |
| Proceeds from contributions to employee stock purchase plan | — | — | — | $1.2m | $1.3m | $1.2m | $1.3m | $1.3m | $1.1m | — | |
| Cash and cash equivalents | — | — | — | — | — | — | $97.3m | $162.3m | $112.2m | $137.5m | |
| Cash paid for income taxes, net of refunds received | — | — | — | $0 | $97k | $133k | $6.2m | $40.4m | $55.5m | — |
Values abbreviated: b = billions, m = millions, k = thousands. Per share data in USD.